Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Acute Respiratory Distress Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Bronchial Asthma
- Respiratory Distress Syndrome, Infant
Acute respiratory distress syndrome (ARDS) is a type of severe, acute lung dysfunction affecting all or most of both lungs that occurs as a result of illness or injury. Although it is sometimes called adult respiratory distress syndrome, it may also affect children. Major symptoms may include breathing difficulties (dyspnea), rapid breathing (tachypnea), excessively deep and rapid breathing (hyperventilation) and insufficient levels of oxygen in the circulating blood (hypoxemia). ARDS may develop in conjunction with widespread infection in the body (sepsis) or as a result of pneumonia, trauma, shock, severe burns, aspiration of food into the lung, multiple blood transfusions, and inhalation of toxic fumes, among other things. It usually develops within 24 to 48 hours after the original illness or injury and is considered a medical emergency. It may progress to involvement of other organs.
Typically, ARDS develops within 24 to 48 hours of the original illness or injury. It may become a life-threatening condition characterized by inflammation of the lungs, which may begin in one lung but eventually affects both, and resulting damage to the air sacs (alveoli) and surrounding small blood vessels. The damaged alveoli close down or fill up with fluid (lung edema), thereby losing their ability to oxygenate the blood and eliminate carbon dioxide. Patients experience increasingly severe respiratory distress, associated with decreasing oxygen levels in arterial blood and tissues.
With the fluid buildup, the lungs become heavy, stiff, and unable to expand properly. Most patients require mechanical ventilation because of respiratory failure. The disorder may also be accompanied or followed by impairment of other vital functions, including cardiovascular, renal, hepatic, hematologic, and neurologic functions. Involvement of other organs in addition to the lungs may lead to a condition sometimes called multi-organ dysfunction syndrome.
The person with ARDS may initially appear agitated as a result of breathing difficulty, but later may become lethargic and or even comatose. He may appear pale, and the hands and feet may have a bluish-gray tone because of the diminished level of oxygen in the blood.
Risk factors for developing acute respiratory distress syndrome include infection in the body (sepsis), pneumonia, extensive trauma, severe low blood pressure (shock), severe burns, aspiration of food into the lung, inflammation of the pancreas, and multiple emergency blood transfusions. The disorder may also follow a near drowning or the inhalation of toxic fumes, or gases such as chlorine, phosgene, and nitrogen dioxide. Acute respiratory distress syndrome may affect people who have previously had healthy lungs, and it may affect children. It is not the same thing as infant respiratory distress syndrome, although the two share some similarities.
Acute respiratory distress syndrome can affect persons of any age who suffer acute injury or illness affecting the lungs. The incidence is believed to be between 1.5 and 4.8 per 100,000 of the population. Men and women appear to be equally affected.
Symptoms of the following disorders can be similar to those of acute respiratory distress syndrome. Comparisons may be useful for a differential diagnosis:
Severe acute respiratory syndrome (SARS) is a respiratory illness that began to be reported in Asia, North America and Europe in the spring of 2003. It begins with a fever greater than 100.4 degrees F. Other symptoms may include headache, an overall feeling of discomfort, body aches, and mild respiratory symptoms. After two to seven days, SARS patients may develop a dry, hacking cough and have trouble breathing. SARS appears to be spread by close person-to-person contact. For additional information on SARS, contact the Centers for Disease Control and Prevention or the World Health Organization.
Pneumonia is an infection of the lungs. Symptoms such as fever, cough, large amounts of mucous production (sputum), fluid in the space surrounding the lungs (pleurisy) and/or chills occur. Chest pain, headache, diarrhea, sore throat and fever blisters may also develop. Shortness of breath, difficulty in breathing, decreased exercise tolerance and night sweats are characteristic. Pneumonia frequently occurs in middle-aged to older adults with various underlying diseases. However, it can occur in persons of all ages, statistically most often in winter and early spring. Pneumonia can be caused by various bacteria, viruses, and other infectious agents.
Respiratory distress syndrome of the infant, also called hyaline membrane disease of the newborn, is characterized by respiratory distress seen especially in premature babies. A clear membrane is found lining the alveolar spaces in the lungs and is associated with reduced amounts of lung wetting agents or emulsifier (surfactant). The surfactant is a lipoprotein that stabilizes alveolar volume. When this surfactant is missing, the affected infant must be placed on some type of ventilator. (For more information on this disorder, choose "Respiratory Distress Syndrome, Infant" as your search term in the Rare Disease Database.)
The diagnosis is based on the presence of respiratory distress accompanied by low levels of oxygen in the blood and the presence of known risk factors such as sepsis, pneumonia, or trauma. Chest x-rays will show fluid filling spaces that should be filled with air. The presence of fluid in the air sacs and the "wet" breathing sounds sometimes made by patients may suggest congestive heart failure but a medical examination will distinguish between that condition and ARDS.
Standard therapy consists of mechanical ventilation, supplemental oxygen, and a technique called positive end expiratory pressure (PEEP) to help push the fluid out of air sacs. These are combined with continuing treatment of the original illness or injury.
Because people with ARDS are less able to fight lung infections, they may develop bacterial pneumonia during the course of the illness. Antibiotics are given to fight infection. Also, supportive treatment such as intravenous fluid or food may be needed. If other organ systems become involved, measures may be needed to support those organs.
The introduction into standard practice of a recent recommendation to use smaller "tidal volumes" (the volume of each individual breath delivered by the ventilator) has resulted in improved outcomes. Earlier, ventilators were set to deliver 12 ml per kg of body weight. Now only 6 ml per kg of body weight are delivered.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Steinbrook R. How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Eng J Med. 2003;348:1393-1401.
Said SI, Dickman KG. Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide. Reg Pept. 2000;93:21-29.
Bernard GR. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Eng J Med. 2000;344:699-709.
Tobin MJ. Culmination of an era in research on the actue respiratory distress syndrome. N Engl J Med. 2000;342:1360-61.
Ware LB, Marthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-39.
Hudson LD, et al. Protective ventilation for patients with acute respiratory distress syndrome. N Eng J Med. 1998;338:385-7.
Amato MBP, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Eng J Med. 1998;338:347-54.
Weg JG, et al. The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. N Eng J Med. 1998;338:341-6.
Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s: systemic inflammatory response and organ dysfunction. JAMA 1994;271:226-33.
Villar J, Slutsky AS. The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis 1989;140:814-16.
American Lung Association
1301 Pennsylvania Ave NW
Washington, DC 20004
NIH/National Heart, Lung and Blood Institute
P.O. Box 30105
Bethesda, MD 20892-0105
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
Nathaniel Adamczyk Foundation
715 Greythorne Road
Wynnewood, PA 19096
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 5/14/2008
Copyright 1989, 1993, 1995, 1996, 1999, 2003, 2004 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.